Virtual Stress Management for Caregiver Stress
(eCare Trial)
Trial Summary
What is the purpose of this trial?
This randomized control trial will investigate the ability of an effective stress management psychoeducation program for employed caregivers to mitigate psychological distress and pathophysiology in spousal or partnered caregivers of patients' diagnosis with a solid tumor cancer of any stage. It is expected that improving caregiver status will have reduced depressive symptoms.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you are using steroid medications chronically, you may not be eligible to participate.
What data supports the effectiveness of the treatment Pep-Pal, PEPRR for managing caregiver stress?
Is the Virtual Stress Management program safe for caregivers?
How is the treatment Pep-Pal, PEPRR different from other treatments for caregiver stress?
Pep-Pal, PEPRR is unique because it is a virtual stress management program specifically designed for caregivers, utilizing internet-based interventions to reduce stress. This approach is novel as it leverages technology to provide support and resources, which are often lacking for home-based caregivers, making it more accessible and convenient compared to traditional in-person methods.256810
Research Team
Cathy J Bradley, PhD
Principal Investigator
University of Colorado Denver (Anschutz Medical Campus)
Eligibility Criteria
This trial is for spouses or partners who have been caregivers for at least a year to someone with any stage of solid tumor cancer and are starting treatment. Caregivers must live with the patient, work at least 20 hours per week, be willing to use a smartphone, and show signs of depression or anxiety.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Caregivers participate in stress management interventions, including Virtual-PEPRR or Pep-Pal, or receive treatment as usual (TAU).
Follow-up
Participants are monitored for psychological and physiological outcomes, including assessments and biomarker collection.
Treatment Details
Interventions
- Pep-Pal
- PEPRR
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
National Cancer Institute (NCI)
Collaborator